Vicore Pharma (Sweden) Price on September 27, 2023

VICO Stock  SEK 7.76  0.04  0.52%   
If you're considering investing in Vicore Stock, it is important to understand the factors that can impact its price. As of today, the current price of Vicore Pharma stands at 7.76, as last reported on the 12th of December 2024, with the highest price reaching 7.89 and the lowest price hitting 7.62 during the day. Vicore Pharma appears to be slightly risky, given 3 months investment horizon. Vicore Pharma Holding owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.0711, which indicates the firm had a 0.0711% return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for Vicore Pharma Holding, which you can use to evaluate the volatility of the company. Please review Vicore Pharma's Risk Adjusted Performance of 0.0379, semi deviation of 2.16, and Coefficient Of Variation of 2379.22 to confirm if our risk estimates are consistent with your expectations.
  
Vicore Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0711

Best PortfolioBest Equity
Good Returns
Average Returns
Small ReturnsVICO
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 2.94
  actual daily
26
74% of assets are more volatile

Expected Return

 0.21
  actual daily
4
96% of assets have higher returns

Risk-Adjusted Return

 0.07
  actual daily
5
95% of assets perform better
Based on monthly moving average Vicore Pharma is performing at about 5% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Vicore Pharma by adding it to a well-diversified portfolio.

Vicore Pharma Valuation on September 27, 2023

It is possible to determine the worth of Vicore Pharma on a given historical date. On September 27, 2023 Vicore was worth 15.22 at the beginning of the trading date compared to the closed value of 15.44. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Vicore Pharma stock. Still, in general, we apply an absolute valuation method to find Vicore Pharma's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Vicore Pharma where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Vicore Pharma's related companies.
 Open High Low Close Volume
  15.20    15.40    15.04    15.34    61,519  
09/27/2023
  15.22    15.56    15.20    15.44    41,528  
  15.38    15.40    15.04    15.22    36,762  
Backtest Vicore Pharma  |  Vicore Pharma History  |  Vicore Pharma Valuation   PreviousNext  
Open Value
15.22
15.44
Closing Value
24.04
Upside

Vicore Pharma Trading Date Momentum on September 27, 2023

On September 28 2023 Vicore Pharma Holding was traded for  15.22  at the closing time. The highest price during the trading period was 15.40  and the lowest recorded bid was listed for  15.04 . The volume for the day was 36.8 K. This history from September 28, 2023 contributed to the next trading day price decline. The trading price change to the next closing price was 1.42% . The trading price change to the current price is 4.53% .

Vicore Pharma Holding Fundamentals Correlations and Trends

By evaluating Vicore Pharma's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Vicore Pharma's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Vicore financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Vicore Pharma Stock history

Vicore Pharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Vicore is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Vicore Pharma Holding will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Vicore Pharma stock prices may prove useful in developing a viable investing in Vicore Pharma
Vicore Pharma Holding AB , through its subsidiaries, operates as a biotech company. Vicore Pharma Holding AB was founded in 2000 and is based in Mlndal, Sweden. Vicore Pharma is traded on Stockholm Stock Exchange in Sweden.

Vicore Pharma Stock Technical Analysis

Vicore Pharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Vicore Pharma technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Vicore Pharma trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Vicore Pharma Period Price Range

Low
December 12, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

Vicore Pharma Holding cannot be verified against its exchange. Please verify the symbol is currently traded on Stockholm Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Vicore Pharma December 12, 2024 Market Strength

Market strength indicators help investors to evaluate how Vicore Pharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Vicore Pharma shares will generate the highest return on investment. By undertsting and applying Vicore Pharma stock market strength indicators, traders can identify Vicore Pharma Holding entry and exit signals to maximize returns

Vicore Pharma Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Vicore Pharma's price direction in advance. Along with the technical and fundamental analysis of Vicore Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Vicore to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Additional Tools for Vicore Stock Analysis

When running Vicore Pharma's price analysis, check to measure Vicore Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vicore Pharma is operating at the current time. Most of Vicore Pharma's value examination focuses on studying past and present price action to predict the probability of Vicore Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vicore Pharma's price. Additionally, you may evaluate how the addition of Vicore Pharma to your portfolios can decrease your overall portfolio volatility.